Interim CEO Tom Hogan highlighted that Cellebrite exceeded its original 2024 revenue and adjusted EBITDA targets, achieving $122 million in free cash flow. He emphasized the company's strong position ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback